HPR60 Diverging Impacts of Evergreening and Biosimilars on Trastuzumab Utilization and Costs in South Korea: Implications for Sustainable Access and Market Competition
Dec 1, 2025, 00:00
10.1016/j.jval.2025.09.1469
https://www.valueinhealthjournal.com/article/S1098-3015(25)04026-4/fulltext
Title :
HPR60 Diverging Impacts of Evergreening and Biosimilars on Trastuzumab Utilization and Costs in South Korea: Implications for Sustainable Access and Market Competition
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)04026-4&doi=10.1016/j.jval.2025.09.1469
First page :
Section Title :
Open access? :
No
Section Order :
11013